Revenue Recognition (Tables)

9 Months Ended

Sep. 30, 2024

Revenue Recognition [Abstract]

Schedule of Disaggregated Revenue

Net Sales by Business
	Three Months				Nine Months
	2024		2023		2024		2023
MedSurg and Neurotechnology:
Instruments	$	679	$	620	$	2,044	$	1,808
Endoscopy	837		746		2,383		2,166
Medical	938		798		2,710		2,417
Neurovascular	329		311		966		906
Neuro Cranial	441		384		1,237		1,112
	$	3,224	$	2,859	$	9,340	$	8,409
Orthopaedics and Spine:
Knees	$	570	$	515	$	1,760	$	1,643
Hips	420		362		1,241		1,130
Trauma and Extremities	849		752		2,511		2,287
Spine	304		291		911		871
Other	127		130		396		343
	$	2,270	$	2,050	$	6,819	$	6,274
Total	$	5,494	$	4,909	$	16,159	$	14,683

Net Sales by Geography
	Three Months 2024				Three Months 2023
	United States		International		United States		International
MedSurg and Neurotechnology:
Instruments	$	544	$	135	$	495	$	125
Endoscopy	689		148		618		128
Medical	783		155		660		138
Neurovascular	121		208		120		191
Neuro Cranial	366		75		315		69
	$	2,503	$	721	$	2,208	$	651
Orthopaedics and Spine:
Knees	$	417	$	153	$	385	$	130
Hips	256		164		231		131
Trauma and Extremities	621		228		550		202
Spine	225		79		217		74
Other	87		40		87		43
	$	1,606	$	664	$	1,470	$	580
Total	$	4,109	$	1,385	$	3,678	$	1,231

Net Sales by Geography
	Nine Months 2024				Nine Months 2023
	United States		International		United States		International
MedSurg and Neurotechnology:
Instruments	$	1,640	$	404	$	1,440	$	368
Endoscopy	1,948		435		1,767		399
Medical	2,261		449		1,954		463
Neurovascular	369		597		361		545
Neuro Cranial	1,014		223		910		202
	$	7,232	$	2,108	$	6,432	$	1,977
Orthopaedics and Spine:
Knees	$	1,279	$	481	$	1,207	$	436
Hips	768		473		716		414
Trauma and Extremities	1,842		669		1,663		624
Spine	675		236		650		221
Other	274		122		233		110
	$	4,838	$	1,981	$	4,469	$	1,805
Total	$	12,070	$	4,089	$	10,901	$	3,782

Contract with Customer, Contract Asset, Contract Liability, and Receivable

Changes in contract liabilities during the nine months 2024 were as follows:

	September 30
	2024
Beginning contract liabilities	$	860
Revenue recognized from beginning of year contract liabilities	(382)
Net advance consideration received during the period	530
Ending contract liabilities	$	1,008